T-Cell Engineering by a Chimeric T-Cell Receptor With Antibody-Type Specificity for the HIV-1 Gp120

Gene Therapy - United Kingdom
doi 10.1038/sj.gt.3302413
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Engineering HIV-Resistant, Anti-Hiv Chimeric Antigen Receptor T Cells

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2017English

Antibodies to the CD4-binding Site of HIV-1 Gp120 Suppress Gp120-Specific CD4 T Cell Response While Enhancing Antibody Response

Infectious Agents and Cancer
Cancer ResearchEpidemiologyOncologyInfectious Diseases
2008English

Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors

Molecular Therapy - Oncolytics
Cancer ResearchOncologyMolecular MedicinePharmacology
2016English

Chimeric Antigen Receptor T Cell Therapies for Multiple Myeloma

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma

International Journal of Hematology
Hematology
2020English

Very Rapid Cloning, Expression and Identifying Specificity of T-Cell Receptors for T-Cell Engineering

PLoS ONE
Multidisciplinary
2020English

Advancing Chimeric Antigen Receptor T Cell Therapy With CRISPR/Cas9

Protein & Cell
BiochemistryBiotechnologyDrug DiscoveryCell BiologyMedicine
2017English

Cytokine Release Syndrome With Chimeric Antigen Receptor T Cell Therapy

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

T-Cell-Receptor Signalling in Inositol 1,4,5-Trisphosphate Receptor (IP3R) Type-1-Deficient Mice: Is IP3R Type 1 Essential for T-Cell-Receptor Signalling?

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy